ACET - Aceto Corporation Summary, Stock Quote and News | Benzinga

Skip to main content

Market Overview

13.18 0 (0%)

Data as of May 18, 2021

Prev. Close 13.18
Price Open
Volume 0
Day's Range -
52 Wk Range 9.71 - 21.4
50 Day Moving Avg. 13.85
PE Ratio
Shares Outstanding 31.80M
Market Cap 419.13M

Trade ACET stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

Adicet Bio Q1 EPS $(0.82) Up From $(2.07) YoY Bill HaddadMon, 17 May 2021 07:15:40 -0400
Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2021 Benzinga InsightsThu, 29 Apr 2021 10:32:00 -0400
JonesTrading Initiates Coverage On Adicet Bio with Buy Rating, Announces Price Target of $33 Benzinga NewsdeskThu, 29 Apr 2021 08:56:13 -0400
Adicet Bio shares are trading higher after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and announced a $27 price target. Benzinga NewsdeskFri, 23 Apr 2021 12:44:34 -0400
Benzinga's Top Ratings Upgrades, Downgrades For April 23, 2021 Benzinga InsightsFri, 23 Apr 2021 10:12:20 -0400
HC Wainwright & Co. Initiates Coverage On Adicet Bio with Buy Rating, Announces Price Target of $27 Benzinga NewsdeskFri, 23 Apr 2021 07:13:02 -0400
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021 Benzinga InsightsWed, 14 Apr 2021 13:20:26 -0400
Adicet Bio shares are trading higher after Canaccord Genuity initiated coverage on the stock with a Buy rating and a price target of $28 per share. Benzinga NewsdeskWed, 14 Apr 2021 10:17:56 -0400
12 Health Care Stocks Moving In Wednesday's Pre-Market Session Benzinga InsightsWed, 14 Apr 2021 09:05:29 -0400
Canaccord Genuity Initiates Coverage On Adicet Bio with Buy Rating, Announces Price Target of $28 Benzinga NewsdeskWed, 14 Apr 2021 07:11:17 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates Globe Newswire20 hours ago
Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit Globe NewswireApr 29, 2021
Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference Globe NewswireApr 15, 2021
Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research Globe NewswireApr 13, 2021
Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Globe NewswireMar 11, 2021
Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B Cell Non-Hodgkin's Lymphoma PRNewswireMar 10, 2021
Adicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors Globe NewswireMar 04, 2021
Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters' Option to Purchase Additional Shares Globe NewswireFeb 16, 2021
Adicet Bio to Participate in Upcoming Investor Conferences Globe NewswireFeb 11, 2021
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement Globe NewswireFeb 10, 2021
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Week 17 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge Seeking AlphaApr 25, 2021
LAVA Therapeutics Seeks $101 Million U.S. IPO Seeking AlphaMar 22, 2021
Adicet Bio launches first-in-human study of ADI-001 in blood cancer Seeking AlphaMar 10, 2021
Adicet: Promising 2021 Therapeutic Initiations, Cash Of $108 Million, And New Management Seeking AlphaDec 28, 2020
Longevity Stocks TalkMarketsDec 14, 2020
IPO Update: IN8bio Proposes Terms For $75 Million IPO Seeking AlphaNov 06, 2020
Stocks To Watch: Big Test For Tech, New IPOs And Fisker Blaze In Seeking AlphaOct 24, 2020
Adicet Bio will not go ahead with 4.5M-stock offering Seeking AlphaSep 22, 2020
Nasdaq to delist two suspended medical companies Seeking AlphaMay 31, 2019
New Mountain Capital acquires ACETO's chemicals business Seeking AlphaApr 16, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q1 2021	EST	Actual	Surprise
EPS:	Expected 2021-05-17
Rev:	Expected 2021-05-17

Q2 2021	EST	Actual	Surprise
EPS:	Expected 2021-07-24
Rev:	Expected 2021-07-24

Start Investing

The Best Online Stock Trading Brokers

Best Free Stock Trading Brokers

Best Forex Brokers

Best Futures Brokers

How to Invest in Real Estate

Best Day Trading Courses